However, restoring the expression of miR-26b dramatically blocked the nuclear translocation of NF-κB, further decreasing the occurrence of NF-κB-mediated chemoresistance of HCC cells to doxorubicin (29). The gene discussed is NFKB1; the disease is hepatocellular carcinoma.